RenovoRx appoints Mark Voll as CFO; Kocak resigns as Principal Accounting Officer but remains Controller

RenovoRx, Inc.

Mark Voll, age 72, appointed CFO effective Feb 4, 2026; also serves as Principal Financial and Accounting Officer.
Ronald B. Kocak resigned as Principal Accounting Officer effective Feb 3, 2026; remains VP and Controller with same salary.
Voll receives $250/hour (50% cash, 50% RSUs) plus initial grant of 60,000 unvested RSUs under 2021 Omnibus Plan.
Voll brings 30+ years finance/accounting experience; led IPOs at Techwell, Montage, Aquantia.
Company generated ~$900K revenue from RenovoCath sales in first nine months of 2025; repeat orders growing.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.